Mylan appoints two new board members

Higgins brings 20 years' experience at Goldman Sachs; Malik has played "key role" in Mylan's diversification, expansion

PITTSBURGH — Mylan has appointed its president and a former Goldman Sachs & Co. partner to its board, the generic drug maker said Monday.

Mylan announced the appointment of president Rajiv Malik and former Goldman Sachs partner Melina Higgins to its board.

Malik has served in various leadership positions at Mylan since January 2007, when it acquired a controlling stake in India-based Matrix Labs Ltd., now known as Mylan Labs Ltd.; Malik was Matrix's CEO at the time. Since then, Mylan said, he has helped expand and diversify the company's global product portfolio, pipeline and manufacturing footprint.

Higgins worked for Goldman Sachs for nearly 20 years, starting there in 1989 and retiring in 2010. While there, she served as a member of the investment committee of the principal investment area, which oversaw and approved global private equity and private debt investments and was one of the largest alternative asset managers in the world. She also served as head of the Americas and as co-chairwoman of the investment advisory committee for the GS Mezzanine Partners funds, managing more than $30 billion of assets.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

Login or Register to post a comment.